Nordisk Archives

Novo Nordisk shares drop 10% after poor weight loss trial result

Suhas Bhokare2 months ago2 months ago01 mins

Unlock the Editor’s Digest at no cost Roula Khalaf, Editor of the FT, selects her favorite tales on this weekly publication. Novo Nordisk has stated a trial for its once-a-week weight loss injection has fallen wanting its goal, sending the Danish drugmaker’s shares 10 per cent decrease on Monday. The 84-week trial discovered that Novo’s…

Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly

Suhas Bhokare2 months ago2 months ago02 mins

Novo Nordisk stock fell 15% Monday after it stated its next-generation weight loss drug did not meet its key purpose of exhibiting that it wasn’t inferior to Eli Lilly’s rival drug. The drug, CagriSema, did not obtain its main endpoint of demonstrating non-inferiority on weight loss when put next to Eli Lilly’s rival drug tirzepatide…